L. Hegedüs

TL;DR: If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered, and steroid prophylaxis is warranted in Graves’ patients with mild/active orbitopathy receiving RAI.

TL;DR: Standardization of the US scanning procedure, techniques of US-guided fine-needle aspiration, and reporting of findings are presented, and definition of criteria for classification of malignancy risk based on cervical US imaging characteristics of neck masses and lymph nodes are presented.

TL;DR: In this dose-selection study, 0.03 mg MRrhTSH was the most efficacious dose as an adjuvant to (131)I therapy of MG and was well tolerated and significantly augmented the effect of (131]I therapy in the short term.

TL;DR: Thyroid patients' risk of work disability is most pronounced in the first year after diagnosis and attenuates in subsequent years, and GO patients have the highest risk ofWork disability.

TL;DR: Older age, lower female to male ratio, more severe, and more active disease cluster around asymmetric Graves’ orbitopathy, asymmetry appears to be a marker of more severe and moreactive disease than other presentations.